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Conformation of the AcrB Multidrug Efflux Pump in Mutants of the
Putative Proton Relay Pathway
Abstract
We previously reported the X-ray structures of wild-type Escherichia coli AcrB, a proton motive force-
dependent multidrug efflux pump, and its N109A mutant. These structures presumably reflect the resting
state of AcrB, which can bind drugs. After ligand binding, a proton may bind to an acidic residue(s) in the
transmembrane domain, i.e., Asp407 or Asp408, within the putative network of electrostatically interacting
residues, which also include Lys940 and Thr978, and this may initiate a series of conformational changes that
result in drug expulsion. Herein we report the X-ray structures of four AcrB mutants, the D407A, D408A,
K940A, and T978A mutants, in which the structure of this tight electrostatic network is expected to become
disrupted. These mutant proteins revealed remarkably similar conformations, which show striking differences
from the previously known conformations of the wild-type protein. For example, the loop containing Phe386
and Phe388, which play a major role in the initial binding of substrates in the central cavity, becomes
prominently extended into the center of the cavity, such that binding of large substrate molecules may become
difficult. We believe that this new conformation may mimic, at least partially, one of the transient
conformations of the transporter during the transport cycle.
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We previously reported the X-ray structures of wild-type Escherichia coli AcrB, a proton motive force-dependent
multidrug efflux pump, and its N109A mutant. These structures presumably reflect the resting state of AcrB, which
can bind drugs. After ligand binding, a proton may bind to an acidic residue(s) in the transmembrane domain, i.e.,
Asp407 or Asp408, within the putative network of electrostatically interacting residues, which also include Lys940
and Thr978, and this may initiate a series of conformational changes that result in drug expulsion. Herein we report
the X-ray structures of four AcrB mutants, the D407A, D408A, K940A, and T978A mutants, in which the structure
of this tight electrostatic network is expected to become disrupted. These mutant proteins revealed remarkably
similar conformations, which show striking differences from the previously known conformations of the wild-type
protein. For example, the loop containing Phe386 and Phe388, which play a major role in the initial binding of
substrates in the central cavity, becomes prominently extended into the center of the cavity, such that binding of
large substrate molecules may become difficult. We believe that this new conformation may mimic, at least partially,
one of the transient conformations of the transporter during the transport cycle.
The Escherichia coli AcrB multidrug efflux pump (10, 11) is
a member of the resistance-nodulation-division transporter
family (18). It recognizes many structurally unrelated toxic
compounds and actively engages to extrude them from cells. Its
crystallographic structure was solved by Murakami et al. (13) in
2002. We previously reported the X-ray structures of AcrB in
the presence of four different ligands (21, 22). The structures
showed that these ligands bind to the wall of the extremely
large central cavity in the transmembrane region of the pump.
This binding presumably corresponds to the first step in the
drug extrusion process, since drug molecules then have to pass
through the periplasmic domain of AcrB and eventually reach
the outer membrane channel TolC. A subsequent study of the
efflux pump by crystallization of a mutant AcrB protein with an
N109A mutation with five structurally diverse ligands (20) in-
dicated that AcrB contains at least two distinct binding sites.
These five ligands not only bind to various positions of the
central cavity but also bind to residues lining the deep external
depression formed by the C-terminal periplasmic domain.
AcrB is a proton motive force-dependent multidrug efflux
pump that functions via a drug/proton antiport mechanism
(23). Coupled with the outward movement of drug molecules,
protons have to flow inward (towards the cytoplasm) to ener-
gize the efflux process. AcrB contains two acidic residues,
Asp407 and Asp408, in the transmembrane (TM) helix TM4
and one basic residue, Lys940, in TM10, and these three res-
idues appear to constitute a salt-bridged (and/or hydrogen-
bonded) network (13, 22) (Fig. 1). The presence of such resi-
dues often means that they play an important functional role,
presumably in the translocation of protons.
For MexB (a homolog of AcrB) of Pseudomonas aeruginosa,
it has been shown that Asp407, Asp408, and Lys939 (corre-
sponding to Asp407, Asp408, and Lys940 of AcrB) are indeed
essential for transport function (7), and this Asp-Lys-Asp triad
was also found to be essential in E. coli AcrB (14). Recently,
we found that Thr978 of AcrB TM11, located close to the triad,
is also essential for function (17); this residue may also be a
component of the putative network of tightly interacting resi-
dues just mentioned (Fig. 1).
During the translocation of the ligand, active transporters
must go through significant conformational changes, which are
coupled to the expenditure of energy. With transporters that
use ATP hydrolysis as an energy source, one can attempt to
trap the transporter in one of the transient conformations by
using vanadate-ADP (5, 16). However, similar approaches are
not feasible with transporters such as AcrB, which is energized
by proton motive force. We reasoned that proton translocation
may perturb the salt bridge/H-bonding interactions within the
D407-K940-T978-D408 complex and that this transient state of
AcrB might be mimicked by replacing one of these residues
with alanine, which cannot be protonated or deprotonated. We
report here that the D407A, D408A, K940A, and T978A mu-
tations cause remarkably similar and extensive alterations in
the conformation of AcrB.
MATERIALS AND METHODS
Construction of D407A, D408A, K940A, and T978A mutants. Mutations were
introduced by the method described in the accompanying paper (17). All of the
mutant acrB genes contained a sequence coding for four additional histidine
residues at the C terminus, and each of the proteins therefore had a hexahistidine
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sequence at the end (together with two histidine residues supplied by the native
AcrB protein).
Purification of AcrB. The mutant AcrB proteins were overproduced in E. coli
BL21-Gold(DE3) cells (Stratagene), using a plasmid derived from pSPORT1
(Invitrogen). Cells were grown in 6 liters of LB medium with 100 g/ml ampi-
cillin. Cells were disrupted with a French pressure cell. The membrane fraction
was collected and washed twice with high-salt buffer containing 20 mM sodium
phosphate (pH 7.2), 2 M KCl, 10% glycerol, 1 mM EDTA, and 1 mM phenyl-
methylsulfonyl fluoride and once with 20 mM HEPES-NaOH buffer (pH 7.5)
containing 1 mM phenylmethylsulfonyl fluoride. The membrane proteins were
then solubilized in 1% n-dodecyl--D-maltoside (wt/vol). Insoluble material was
removed by ultracentrifugation at 370,000  g. The extracted protein was puri-
fied with hydroxyapatite and Cu2-affinity columns (23).
Crystallography. Crystals of the D407A, D408A, K940A, and T978A mutants
were grown by hanging-drop vapor diffusion at 25°C. A protein solution contain-
ing 30 mg/ml mutant protein in 20 mM Tris (pH 7.5), 0.1% n-dodecyl--D-
maltoside, and 20 mM dithiothreitol was mixed with an equal volume of a
reservoir solution containing 6.5 to 8.5% polyethylene glycol 3000, 8% glycerol,
and 30 mM sodium citrate (pH 5.6) or 30 mM potassium citrate (pH 6.5).
Crystals appeared in the drops within 4 days. Cryoprotection was achieved by
raising the glycerol concentration stepwise to 35%, with a 5% increment at each
step. The conditions used for crystallization were essentially identical to those
used earlier for the wild-type AcrB protein (22), except for the pH of the Tris
buffer used. When the wild-type protein was crystallized under the conditions
described here, a structure identical to that reported earlier was obtained (un-
published results).
All X-ray intensity data sets were collected at the Advanced Light Source at
Lawrence Berkeley National Laboratory (beamline 8.2.1) at a cryogenic temper-
ature (100 K). The diffraction data were processed with DENZO and scaled with
SCALEPACK (15). The crystals of the AcrB mutants took the R32 space group,
with the unit cell dimensions listed in Table 1. Initially, the overall structures of
the AcrB mutants were determined by molecular replacement, using the MolRep
program (19) in the CCP4 package. The wild-type AcrB structure (Protein Data
Bank no. 1OY6) was used as a search model. Before refinement, 5% of all data
were set aside for cross-validation (2). The model refinements were per-
formed using CNS (3) and CCP4 (4). Model rebuilding was conducted using
the program O (8).
Labeling of purified CL-F386C AcrBHis mutant proteins with MIANS and
fluorescence measurements. The acrB gene was first modified by converting the
codons for two intrinsic cysteines (Cys493 and Cys887) to those for serines by
site-directed mutagenesis, producing cysteine-less (CL) AcrB; this mutant pro-
tein appeared to be fully functional in providing drug resistance, as reported
earlier for proteins with alanine mutations of the same residues (6). Phe386 in
CL AcrB was then converted to cysteine, and another mutation in the proton
relay region was introduced, when necessary, in the same way. The purified
CL-F386C AcrBHis proteins (3 to 4 mg/ml in 20 mM HEPES-KOH buffer
containing 50 mM NaCl, 0.02% n-dodecyl--D-maltoside, and 10% glycerol [pH
7.5]) were diluted in the assay buffer (20 mM HEPES-KOH [pH 7.5] containing
50 mM NaCl and 0.02% n-dodecyl--D-maltoside) at a concentration of 0.5 M
(57 g/ml). The reaction was initiated by the addition of 2-(4-maleimidylanilino)
naphthalene 6-sulfonic acid sodium salt (MIANS; Molecular Probes) to a final
concentration of 5 M, and fluorescence was monitored continuously at room
temperature with an RF-5301PC spectrofluorophotometer (Shimadzu) at an
emission wavelength of 430 nm (excitation, 330 nm). A similar labeling experi-
ment was also carried out by using 7-diethylamino-3-(4-maleimidylphenyl)-
4-methylcoumarin (CPM; Molecular Probes).
Protein structure accession numbers. The coordinates for the protein struc-
tures have been deposited in the Protein Data Bank (PDB) under accession
numbers 2HQC (D407A mutant), 2HQD (D408A mutant), 2HQF (K940A mu-
tant), and 2HQG (T978A mutant).
RESULTS
Crystallographic structures of mutants of the putative pro-
ton relay system. We solved the three-dimensional structures
of the AcrB D407A, D408A, K940A, and T978A mutants by
X-ray crystallography through molecular replacement. The
structures were determined with a maximum resolution of 3.38
to 3.65 Å. The overall Rwork values were between 25.1 and
27.1%, and Rfree values were between 27.5 and 30.3%. Refine-
ment statistics are shown in Table 1. The overall structures of
FIG. 1. Putative salt bridge/H-bonding network (D407-D408-
K940-T978) in the wild-type AcrB protomer, based on PDB file 1IWG
(15). The view is along the line perpendicular to the membrane sur-
face, from the periplasmic side. In spite of the modest resolution of the
overall structure, the electron densities of some side chains can be seen
clearly (see Fig. 2, top panel). The stick model in this figure as well as
that in Fig. 6B was produced by the program PyMol (W. L. Delano,
PyMol Graphic System [www.pymol.org]). The locations and sizes of
the cross sections of TM4, TM10, and TM11 shown are crude approx-
imations added simply to aid understanding.
TABLE 1. Data collection and crystallographic analysis of AcrB mutantsa






D407A mutant a  b  145.4, c  514.5,
    90, 	  120
3.56 (3.78–3.56) 100 (94.7) 10.2 (35.9) 27.1/29.4 1,086,717 41,936 3.9
D408A mutant a  b  145.0, c  513.7,
    90, 	  120
3.65 (3.78–3.65) 94.7 (92.3) 10.6 (46.5) 26.1/30.3 618,639 23,658 1.3
K940A mutant a  b  145.6, c  519.7,
    90, 	  120
3.38 (3.56–3.38) 99.9 (99.0) 7.8 (45.8) 25.1/28.0 880,107 43,054 1.4
T978A mutant a  b  144.9, c  518.6,
    90, 	  120
3.38 (3.56–3.38) 99.1 (94.6) 9.3 (49.1) 25.4/27.5 1,112,163 42,367 2.7
a All mutants belong to space group R32. Numbers in parentheses are for the highest-resolution shells.













these mutant proteins were very similar to each other. Each
mutant protein formed a homotrimer, with its threefold sym-
metry axis passing through the center of the trimer. Compared
with wild-type AcrB, the mutant transporters showed some
unique conformational changes, as described below.
Short-range alterations. Electron density omit maps showed
that some of the tight interactions among four residues,
namely, Asp407, Asp408, Lys940, and Thr978 (Fig. 1), became
profoundly disturbed in the mutants. As shown in Fig. 2 (top
panel), in the wild-type protein the side chains of some of these
residues show clearly interpretable electron densities, even at
the modest overall resolution of our structures, presumably
because they are immobilized by the strong electrostatic inter-
actions between them. However, in the mutant proteins (Fig. 2,
bottom panel, shows the same region in the D408A mutant
protein as an example), much less detail of the side chain
density is seen, most likely because the tight interaction net-
work was disturbed.
This disorder in the network region, introduced by the mu-
tations, apparently spreads into the neighboring regions. Thus,
in all four mutants, extensive changes occur in the backbone
atoms in the part of TM4 that is proximal to residue 407 (Fig.
3). Thus, the regular H-bonding interactions of the backbone
NH and CAO groups characteristic of the -helix (Fig. 3, left
panel) become distorted or disrupted (the right panel of Fig. 3
shows the D407A mutant as an example; similar changes are
also found in the other mutants), as also seen in the disappear-
ance of regular helical structures in the upper part of TM4 in
Fig. 4 (bottom panel), where the structure of the TM domain
of the K940A mutant is given as an example. The disordering
of the proximal part of TM4, as illustrated in Fig. 3, makes this
segment longer, also creating a drastic change in the positions
of residues of the loop between TM helices 3 and 4 (noted by
an arrow on the left in Fig. 5). This loop is located close to the
ceiling of the central cavity, and the details, which could be
established unequivocally because of the electron density of
the phenyl groups in Phe386 and Phe388, are shown in Fig. 6B
(panel A shows the electron density maps of the wild-type
protein and the K940A mutant protein). Compared with the
wild-type structure (Fig. 6B, left panel), the loops of all mu-
tants, formed by residues 384 to 393 between TM3 and TM4,
intrude prominently into the center of the cavity (Fig. 6B, right
panel). The change includes residues Phe386 and Phe388 com-
ing about 6 to 7 Å closer to the center of the cavity, and thus
also to their counterparts from the other subunits of the trimer.
FIG. 2. Side view of the putative proton relay network involving
TM4 and TM10. Electron density omit maps were calculated at 1 .
(Top) In wild-type AcrB, some of the side chains are visible, presum-
ably because of the strong electrostatic interactions among these res-
idues. (Bottom) In contrast, in mutants (the D408A mutant is shown as
an example), much less detail can be seen, presumably because of the
weakening and abolition of the electrostatic interactions.
FIG. 3. Structure of the N-terminal portion of TM4. The view is
from the side (in a direction parallel to the membrane surface). The
hydrogen bonds (green dotted lines) were calculated by the program
DeepView, and the picture was drawn by using DeepView and POV-
ray. The wild-type structure (left) and the D407A mutant structure
(right) were aligned for the best overall fit of the entire protein back-
bone by DeepView and then horizontally displaced for a better view.
In the wild-type AcrB protein (left), the backbone NH of Asp407 is
H-bonded to the backbone CAO of Gly403, four residues back, as it
should be in the regular -helical structure. However, in the D407A
mutant AcrB protein (right), the corresponding NH of Ala407 appears
to H-bond to the CAO of not only Gly403 but also Leu404, distorting
the helix. Further upward, the H-bonding interactions involving NH
groups of Leu405, Leu404, and Gly403 in the wild-type protein are
totally lost in the mutant protein. This distortion of the -helix
extends the chain, such that the top of TM4 (near the top of the
figure) becomes higher in position in the mutant protein by nearly
2 Å, as shown.













For example, the distances between the CZ carbon atoms of
the phenyl groups of Phe386 and Phe386 in the D407A,
D408A, K940A, and T978A mutants are 6.7 Å, 6.0 Å, 6.2 Å,
and 7.4 Å, respectively, in contrast to 16.2 Å in the wild-type
protein. These three phenylalanines essentially decrease the
size of the upper part of the central cavity by forming a
septum-like structure (Fig. 6C), resulting in an opening of
only about 6 Å in diameter at this region, in contrast to the
nearly 20-Å-diameter opening in the wild-type protein.
Long-range alterations. The local changes were propagated
to produce a number of remarkably extensive long-range
alterations, as shown in Fig. 4. Thus, looking at the K940A
mutant protein, the kinked TM helix 5 becomes disordered
FIG. 4. Secondary structures in TM domains. The figure was drawn
by using the Cn3D program (National Center for Biotechnology Infor-
mation) after alignment of the three-dimensional structures of the wild
type (PDB file 1IWG) and the K940A mutant (this study) through the
Vector Alignment Search Tool (12), available at the National Center for
Biotechnology Information website. Note that the assignment of the sec-
ondary structure was done in a uniform manner by the Vector Alignment
Search Tool program, independent of the annotations in the PDB files.
The TM helices are numbered in the wild-type structure.
FIG. 5. Global conformation of AcrB protomers, showing the de-
viation of the K940A structure from the wild-type structure. The struc-
tures were aligned for the best global fit, using backbone atoms, by the
Iterative Magic Fit feature of the DeepView program, and the mutant
structure was colored in rainbow colors (with red showing the most
deviation) by using the “color by RMS deviation” feature of the pro-
gram, whereas the wild-type structure is shown in white. The structure
is shown so that the helices on the right side correspond to the N-
terminal ones (TM1 through TM6) and those on the left side corre-
spond to the C-terminal ones (TM7 through TM12). The structure is
tilted slightly from the membrane perpendicular in order to show the
loop between TM3 and TM4 more clearly. The shift of this loop
between TM3 and TM4 is indicated by an arrow on the left, and that
of the loop of residues 29 to 34 is shown by an arrow on the right. The
shift of the loop at the bottom of the periplasmic ligand binding site
(23) is indicated by an arrowhead. Red sections at the extreme left
portion of the figure are an artifact caused by the absence of some
residues in the wild-type structure. The drawing was done by using
DeepView and POV-ray.













such that the helical structure before the kink totally disap-
pears, and even the portion after the kink becomes strongly
disordered. The following TM6 helix also becomes shortened.
Furthermore, the helix connecting the N-terminal and C-ter-
minal halves of the transmembrane domain, i.e., I (13), again
becomes drastically shortened. The TM helices of the C-ter-
minal half (TM7 through TM12) do not undergo extensive
disordering, except that helix 11 (containing Thr978) be-
comes somewhat shorter and the C-terminal end of helix 12
becomes disordered. All of these changes occur with re-
markable regularity in all four mutants (K940A, D407A,
D408A, and T978A).
As part of this global conformational alteration, we found
that the upper half of TM5 shifts upward about 2 Å, just like
the corresponding part of TM4. Significant backbone move-
ment was also found in the flexible loop, i.e., residues 29 to 32,
above TM1 (the electron density map of this region is also
shown in Fig. 6A, and the shift is highlighted with an arrow on
the right in Fig. 5). This loop forms one side of the vestibule
through which ligands are hypothesized to enter the central
cavity (13, 21, 22). The displacement can be interpreted as a
rotation of this portion of the loop, with the rotational axis
passing through the C- atoms of residues 28 and 32. The side
chain of Leu30, which is at the center of this displaced region,
appears to have been flipped about 100° from the central
cavity. The rotation also shifts the locations of the C- atoms
of Leu30 and Pro31 about 5 Å away from their original posi-
tions. The movement of this region occurs in a direction
opposite (that is, away from the cavity) from that of the
nearby loop between TM3 and TM4 mentioned earlier (into
the cavity).
Many regions of the periplasmic domain are also altered. It
is intriguing that the loop that forms the bottom and part of the
“left” wall of the periplasmic drug binding site (20) is shifted
significantly (indicated by an arrowhead in Fig. 5). The side
chain of one of the residues that appear to be involved in
ligand binding, Glu673 (see Fig. 5 in reference 20), is part of
this shifted region, and in our model its side chain is moved
away from the position of bound ligand about 6 Å in compar-
ison with the position in the wild-type protein.
Accessibility of the loop between TM3 and TM4. The con-
formational alterations observed in the mutant AcrB proteins
FIG. 6. Structure of the loop between TM3 and TM4. (A) Simu-
lated annealing composite omit map of the K940A mutant contoured
at 1.0 . The figure shows the locations of Phe386 and Phe388 in the
central cavity and of residues along the left side of the vestibule.
(B) Models of the loop (residues 385 to 389) viewed along the three-
fold axis (perpendicular to the membrane surface) from the periplas-
mic side. The left panel shows the structure in wild-type AcrB (from
PDB file 1IWG) (15), and the right panel shows the structures in
mutant AcrB proteins (D407A, green; K940A, mauve; and T978A,
orange) overlaid on top of the wild-type structure (yellow). (C) Ver-
tical slab (5 Å thick) of the AcrB trimer, showing the essential closure
of the top portion of the central cavity by the loop between TM3 and
TM4 in the K940A mutant protein (right). The same slab of the
wild-type trimer is shown on the left for comparison. The slice plane
goes through the approximate center of the central cavity as well as
through the Pro833 residue in protomer A and Thr145 in protomer B.
The picture was generated by the Deep View program followed by
POV-ray.













were extensive. Although the crystallization conditions were
similar to those employed earlier (21, 22), we wanted noncrys-
tallographic evidence to strengthen our conclusion that the
region involving Phe386 and Phe388 is indeed altered strongly
in its conformation in the mutant proteins. We therefore mu-
tated the Phe386 residue to cysteine and examined the acces-
sibility of this residue for modification with fluorescent male-
imide reagents. As shown in Fig. 7, Cys386 mutant AcrB
proteins containing additional mutations in the putative proton
relay complex (D407A, D408A, K940A, and T978A) were
modified by MIANS significantly more rapidly than the protein
not containing any second mutation. Because the fluorophore
of MIANS (anilinonaphthalene sulfate) is affected by its envi-
ronment in terms of its fluorescence, we also used a coumarin
maleimide (CPM), which is much less sensitive to its environ-
ment, and obtained similar results (not shown). These results
suggest that the conformation of the region between TM3 and
TM4 is indeed altered in the D407A, D408A, K940A, and
T978A mutants.
DISCUSSION
In previously determined structures of AcrB, the side
chains of Asp407, Asp408, Lys940, and Thr978 are close to
each other and appear to form a salt bridge/hydrogen-bond-
ing network (Fig. 1). It may be postulated that AcrB in this
“resting-state” conformation is ready to bind substrates, as
the central cavity of this conformer has indeed been shown
to bind various drugs (22).
As a working hypothesis, we assumed that the ε-amino group
of Lys940 is protonated and the carboxyl groups of Asp407 and
Asp408 are deprotonated, in view of their close proximity (17).
During the process of proton translocation, one of the carboxyl
groups, perhaps that of Asp407, can be postulated to become
protonated. This is similar to what has been assumed for many
active transporters energized by proton motive force (for ex-
ample, see the case of the lactose permease LacY [1]). This
protonation of an acidic residue is expected to disturb the tight
salt bridge/hydrogen-bonding network of the four residues,
distort the positions of these residues relative to each other,
and initiate a series of conformational changes that would
result in the transport of drugs, as stated in the accompanying
paper (17).
We undertook this study on the assumption that disturbing
the interactions among Asp407, Asp408, Lys940, and Thr978
might in some way mimic the consequences of protonation of
one of the carboxyl residues. Indeed, we found that conversion
of any of these residues to alanine produced a widespread
conformational alteration (Fig. 3 to 6). It is also remarkable
that mutation of any of the four residues produced nearly
identical new conformations, suggesting that the trigger for
change is the disruption of the same salt bridge/H-bonding
network. Although it may be argued that the replacement of a
charged residue with an uncharged Ala residue may disturb the
protein structure simply because of the unfavorable thermo-
dynamics of insertion of the remaining charged residues into
the membrane, without any relation to H translocation, the
same altered conformation in the T978A protein, where
charged residues have not been altered, refutes this interpre-
tation.
The new conformation shows that the TM domains of the
three protomers still form a large central cavity with a diameter
of about 35 Å. However, the diameter of this central cavity
decreases to about 6 Å in a region close to the ceiling due to
the protrusion of the loop containing Phe386 and Phe388 (Fig.
6). This is the loop that forms a multidrug binding site in
wild-type AcrB (22), but this region may become too tight to
bind large drugs in these AcrB mutants. If we assume that the new
conformation mimics one of the transient stages after the binding
of drugs by resting-state AcrB, it may be that the conformational
alteration induced by protonation pushes the drug molecules
away from the initial site to a new position closer to the final
stage of their expulsion. Drug binding studies, both biochem-
ical and crystallographic, are obviously needed to follow up this
hypothesis.
Compared with the trimer of wild-type AcrB, there is an
increase in intersubunit distance in the mutant homotrimers.
For example, the distance between the top regions of TM1 and
TM8 from adjacent subunits is increased about 2 Å in the
K940A structure. This change opens the vestibule located
above these TM helices some 3 Å. It also enlarges the bottom
of the cavity opened to the cytoplasm by 2 Å. Similar changes
were found in the other mutant AcrB proteins. Anisotropic
network model calculations (9) showed that the motion in the
central cavity of AcrB is dominated by breathing vibrational
modes. We suspect that the expansion of the AcrB mutants
mimics this breathing motion.
Our hope was that the conformation of the mutant pro-
teins would give us not only a glimpse of the transitional
states of the AcrB transporter during a normal cycle, but
also hints on the pathway of drug molecules during export,
especially within the periplasmic domain. However, alter-
ations were not extensive in the conformation of the periplasmic
FIG. 7. Reaction of purified CL-F386C AcrBHis mutants with the
fluorescence probe MIANS. MIANS labeling was carried out with 0.5
M purified protein in 2 ml of 20 mM HEPES-KOH (pH 7.5)–50 mM
NaCl–0.02% dodecyl maltoside. Reactions were initiated by the addi-
tion of MIANS to a final concentration of 5 M, and the fluorescence
increase was recorded continuously at 430 nm (excitation, 330 nm).
Mutants were as follows: 1, CL-F386C; 2, CL386-N109A; 3, CL386-
D407A; 4, CL386-D408A; 5, CL386-K940A; and 6, CL386-T978A.













domain (Fig. 5), and the reasons for this outcome are not
known.
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ADDENDUM IN PROOF
After this paper was accepted for publication, two papers
(M. A. Seeger, A. Schiefner, T. Eicher, F. Verrey, K. Died-
erichs, and K. M. Pos, Science 313:1295–1298, 2006; S. Mu-
rakami, R. Nakashima, E. Yamashita, T. Matsumoto, and A.
Yamaguchi, Nature, on-line 16 August 2006) describing an
asymmetric trimer structure of AcrB have appeared. One of
the AcrB protomers in this asymmetric structure, called the O
or extrusion unit, is described as having a disrupted interaction
in the D407-D408-K940-T978 network. Some features of our
mutant structure model resemble this subunit: for example,
there are, in both structures, an extension of the N-terminal
(upper) end of the TM helix 8 (Fig. 4), the reorientation of the
Lys940 side chain, and the movement of the PC2 periplasmic
domain toward the PC1 domain.
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